1. Home
  2. ELTX vs IDN Comparison

ELTX vs IDN Comparison

Compare ELTX & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$3.04

Market Cap

81.2M

Sector

Health Care

ML Signal

HOLD

Logo Intellicheck Inc.

IDN

Intellicheck Inc.

HOLD

Current Price

$2.99

Market Cap

73.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
IDN
Founded
2011
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
81.2M
73.5M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
ELTX
IDN
Price
$3.04
$2.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$18.00
$7.33
AVG Volume (30 Days)
269.9K
428.5K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
39.29
220.00
EPS
N/A
0.06
Revenue
$2,301,000.00
$4,433,454.00
Revenue This Year
N/A
$12.54
Revenue Next Year
N/A
$15.32
P/E Ratio
N/A
$51.00
Revenue Growth
N/A
23.21
52 Week Low
$2.66
$2.70
52 Week High
$16.00
$9.08

Technical Indicators

Market Signals
Indicator
ELTX
IDN
Relative Strength Index (RSI) 41.08 30.43
Support Level $2.72 N/A
Resistance Level $3.28 $4.49
Average True Range (ATR) 0.17 0.19
MACD 0.12 -0.07
Stochastic Oscillator 51.24 22.05

Price Performance

Historical Comparison
ELTX
IDN

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company includes solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

Share on Social Networks: